FDA Debars Man from Drug Industry for Unauthorized Import and Sale of Omeprazole
The Food and Drug Administration issued an order debarring Ashley Brandon Foyle for five years from providing services to any person that has an approved or pending drug product application, in connection with his 2010 conviction for introducing and delivering…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
into commerce a misbranded drug. Foyle had imported omeprazole from Muhi Trading Corporation, and his company Omega Biotech had repackaged and sold the drug. Neither Foyle, Omega, or Muhi Trading were registered to manufacture, prepare, propagate, compound, or process drugs, FDA said.